Gene therapy enhances deoxyribonuclease I treatment in antimyeloperoxidase glomerulonephritis
JCI Insight · 2025
DOI: 10.1172/jci.insight.188951 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCI Insight, 2025. Verfasst von Anne Cao Le und 13 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Inflammatory Diseases, Monash University Department of Medicine, Clayton, Victoria, Australia. Hauptthemen laut MEDLINE: Deoxyribonuclease I, Glomerulonephritis, Peroxidase, Genetic Therapy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council of Australia, Rebecca L Cooper Foundation.
Abstract (Originalsprache)
Extracellular DNA (ecDNA) released from injured and dying cells powerfully induces injurious inflammation. In this study we define the role of ecDNA in systemic vasculitis affecting the kidney, using human kidney biopsies and murine models of myeloperoxidase anti-neutrophil cytoplasmic antibody-associated glomerulonephritis (MPO-ANCA GN). Twice daily administration of intravenous deoxyribonuclease I (ivDNase I) in 2 models of anti-MPO GN reduced glomerular deposition of ecDNA, histological injury, leukocyte infiltration, and NETosis. Comprehensive investigation into DNase I modes of action revealed that after exposure to MPO, DNase I reduced lymph node DC numbers and their activation status, resulting in decreased frequency of MPO-specific CD4 + effector T cells (IFN-γ and IL-17A producing) and reductions in dermal anti-MPO delayed type hypersensitivity responses. To overcome the translational obstacle of the short half-life of DNase I (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Inflammatory Diseases, Monash University Department of Medicine, Clayton, Victoria, Australia.
- Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia.
- Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia.
- Gene Therapy Research Unit, Children's Medical Research Institute and Sydney Children's Hospitals Network, University of Sydney, New South Wales, Sydney, Australia.
- Discipline of Child and Adolescent Health, University of Sydney, Sydney, New South Wales, Australia.
- Departments of Nephrology and Pediatric Nephrology, Monash Health, Melbourne, Victoria, Australia.
Förderung
- National Health and Medical Research Council of Australia
- Rebecca L Cooper Foundation
Zitieren
APA
Cao Le, A., Oudin, V., Dick, J., Alikhan, M. A., Gottschalk, T. A., Lu, L., Lawlor, K. E., Koo Yuk Cheong, D., Mandwie, M., Alexander, I. E., Kitching, A. R., Gan, P. Y., Logan, G. J., & O'Sullivan, K. M. (2025). Gene therapy enhances deoxyribonuclease I treatment in antimyeloperoxidase glomerulonephritis. JCI Insight. https://doi.org/10.1172/jci.insight.188951
Vancouver
Cao Le A, Oudin V, Dick J, Alikhan MA, Gottschalk TA, Lu L, et al. Gene therapy enhances deoxyribonuclease I treatment in antimyeloperoxidase glomerulonephritis. JCI Insight. 2025. doi:10.1172/jci.insight.188951
BibTeX
@article{CaoLe2025,
author = {Cao Le, Anne and Oudin, Virginie and Dick, Jonathan and Alikhan, Maliha A and Gottschalk, Timothy A and Lu, Lu and Lawlor, Kate E and Koo Yuk Cheong, Daniel and Mandwie, Mawj and Alexander, Ian E and Kitching, A R and Gan, Poh-Yi and Logan, Grant J and O'Sullivan, Kim M},
title = {Gene therapy enhances deoxyribonuclease I treatment in antimyeloperoxidase glomerulonephritis},
journal = {JCI Insight},
year = {2025},
doi = {10.1172/jci.insight.188951}
}
EUVIMED